Characterization of Protein Therapeutics using Mass Spectrometry
Editat de Guodong Chenen Limba Engleză Paperback – 6 iun 2015
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 1176.12 lei 6-8 săpt. | |
Springer Us – 6 iun 2015 | 1176.12 lei 6-8 săpt. | |
Hardback (1) | 1180.21 lei 6-8 săpt. | |
Springer Us – 6 mai 2013 | 1180.21 lei 6-8 săpt. |
Preț: 1176.12 lei
Preț vechi: 1434.29 lei
-18% Nou
Puncte Express: 1764
Preț estimativ în valută:
225.09€ • 237.43$ • 188.12£
225.09€ • 237.43$ • 188.12£
Carte tipărită la comandă
Livrare economică 01-15 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781489973641
ISBN-10: 1489973648
Pagini: 416
Ilustrații: X, 404 p.
Dimensiuni: 155 x 235 x 22 mm
Greutate: 0.58 kg
Ediția:2013
Editura: Springer Us
Colecția Springer
Locul publicării:New York, NY, United States
ISBN-10: 1489973648
Pagini: 416
Ilustrații: X, 404 p.
Dimensiuni: 155 x 235 x 22 mm
Greutate: 0.58 kg
Ediția:2013
Editura: Springer Us
Colecția Springer
Locul publicării:New York, NY, United States
Public țintă
Professional/practitionerCuprins
Characterization of Protein Therapeutics by Mass Spectrometry: Recent Developments and Future Directions.- The Use of Mass Spectrometry to Characterize the Metabolism of Peptide Therapeutics.- Quantitative Analysis of Biologics Using Mass Spectrometry.- Maximizing Structural Information from Whole Protein Tandem Mass Spectrometry.- Disulfide Linkages of an Albumin Fusion Protein.- Detailed Structural Characterization of Monoclonal Antibodies.- Application of Protein Mass Spectrometry in Impurity and Degradant Characterization.- Mass Spectrometry Methods to Analyze Higher Order Structure of Protein Therapeutics by Chemical Footprinting.- Aglycosylations Alters Protein Conformation in Antibodies Engineered with Specific Effector Functions Using HDX-MS.- Characterizing Biotherapeutic Protein 3D Structures by Electrospray Ion-Mobility Mass Spectrometry.- Oxford University, Characterization of Assemblies of Proteins by Mass Spectrometry.
Notă biografică
GUODONG CHEN, PHD, has extensive pharmaceutical research experience in major pharmaceutical companies, including Eli Lilly and Company, Schering-Plough and Bristol-Myers Squibb. Currently, he heads the analytical/mass spectrometry group at Bristol-Myers Squibb’s Princeton site in support of drug discovery programs and development projects in small molecule pharmaceuticals and biologics. He has over 65 research publications in peer-reviewed journals and book chapters, and three edited/co-edited books in pharmaceutical analysis. His other contributions to the scientific community include over 80 presentations at scientific conferences and academic institutes; service as a short course instructor, as session chair at various scientific forums, and as a reviewer for journals. He received his Ph.D. in Analytical Chemistry from Purdue University under the direction of Professor R. Graham Cooks.
Textul de pe ultima copertă
Protein therapeutics’ high efficacy, safety, and ability to treat life-threatening diseases such as cancer, inflammation and genetic disorders have revolutionized modern medicine. In 2012, 200 companies competed in this $90 billion year industry.
In Characterization of Protein Therapeutics using Mass Spectrometry, expert contributors from academia and industry highlight current approaches and future trends. The book discusses mass spectrometry techniques as related to the analysis of protein therapeutics, structural identification strategies and quantitative approaches. The book also covers various studies involving characterization of process related protein drug impurities/degradants, metabolites, PTMs and higher order structures of protein therapeutics.
General practitioners in pharmaceutical research, specialists in analytical sciences, and graduate students studying mass spectrometry and pharmaceutical sciences will find this book useful because of the step-by-step approaches and new strategies to solve challenging problems related to protein therapeutics research and development.
In Characterization of Protein Therapeutics using Mass Spectrometry, expert contributors from academia and industry highlight current approaches and future trends. The book discusses mass spectrometry techniques as related to the analysis of protein therapeutics, structural identification strategies and quantitative approaches. The book also covers various studies involving characterization of process related protein drug impurities/degradants, metabolites, PTMs and higher order structures of protein therapeutics.
General practitioners in pharmaceutical research, specialists in analytical sciences, and graduate students studying mass spectrometry and pharmaceutical sciences will find this book useful because of the step-by-step approaches and new strategies to solve challenging problems related to protein therapeutics research and development.
Caracteristici
First book to focus on characterization by mass spectrometry of protein drugs Well-known Volume Editor with strong ties to pharmaceutical industry and analytical chemistry Internationally recognized contributors who are top experts in the field